India Antimalarial Drugs Market Research 2024: Competitive Landscape, Key Trends, Forecast & Opportunities, 2020-2030
09 oct. 2024 10h44 HE
|
Research and Markets
Dublin, Oct. 09, 2024 (GLOBE NEWSWIRE) -- The "India Antimalarial Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's...
Global Artemisinin Combination Therapy Market (2022-2027): An Artemisinin-Based Combination of Multiple Medicines That Are Matched in Terms of Half-Life Might Be the Future of Malaria Treatment
23 nov. 2023 10h13 HE
|
Research and Markets
Dublin, Nov. 23, 2023 (GLOBE NEWSWIRE) -- The "Global Artemisinin Combination Therapy Market (2022-2027) by Combination Therapy Type, and Geography, Competitive Analysis and the Impact of Covid-19...
Global Global Antimalarial Drugs Market Research Report 2022: Increasing Prevalence of Malaria Coupled with Surge in Research for New Drugs to Propel Growth - Forecasts to 2028
17 févr. 2023 06h48 HE
|
Research and Markets
Dublin, Feb. 17, 2023 (GLOBE NEWSWIRE) -- The "Global Antimalarial Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Drug Type, By Drug Class, By...
Manus Bio Awarded Additional Funding to Support its Artemisinin Development Program
01 avr. 2021 10h38 HE
|
Manus Bio
CAMBRIDGE, Mass., April 01, 2021 (GLOBE NEWSWIRE) -- Manus Bio Inc. (Manus Bio), a company which produces complex natural products through advanced fermentation, announced today that it has received...
MATEON’S GLOBAL STUDY FOR ARTEMISININ INTERVENTION AGAINST COVID-19 CLEARED FOR PATIENT ENROLLMENT IN INDIA.
14 sept. 2020 07h00 HE
|
Mateon Therapeutics, Inc.
AGOURA HILLS, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics “Mateon” (OTC.QB: MATN), a leading developer of TGF-β therapeutics for oncology and COVID-19, announced today that its...
MATEON THERAPEUTICS AND ABIOGENESIS TO INITIATE CLINICAL STUDY TO TEST ARTEMISININ AS A TREATMENT FOR COVID-19 IN INDIA
04 août 2020 07h00 HE
|
Mateon Therapeutics, Inc.
AGOURA HILLS, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics (OTCQB: MATN), a leading developer of TGF-β therapeutics, will be working together with Abiogenesis to initiate ARTI-19...
Manus Bio Awarded Next Stage of Funding to Continue Development of a Novel Production Method for Artemisinin
09 mai 2019 11h32 HE
|
Manus Bio
CAMBRIDGE, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Manus Bio Inc. (Manus Bio), a company which produces complex natural products through advanced fermentation, announced today that it has received...
Manus Bio Awarded Funding to Develop Novel Production Method for Artemisinin
11 janv. 2018 10h51 HE
|
Manus Bio
CAMBRIDGE, Mass., Jan. 11, 2018 (GLOBE NEWSWIRE) -- Manus Bio Inc. (Manus Bio), a company which produces complex natural products through advanced fermentation, announced today that it has received...